IPP Bureau
Lupin inks US licensing deal with Valorum for biosimilar Armlupeg
By IPP Bureau - December 05, 2025
Valorum will advance the commercialization and distribution of Armlupeg in the United States
Medtronic and Symbiosis International inaugurate center for advanced surgical, cadaver-based training
By IPP Bureau - December 05, 2025
The center will offer training to super-specialist doctors and healthcare professionals in various fields
Granules’ packaging facility in US completes FDA inspection with zero observations
By IPP Bureau - December 05, 2025
Granules Consumer Health serves as Granules’ front-end division for OTC products in the US
Fortis ropes in 'Yamraj' to launch nationwide helmet safety drive
By IPP Bureau - December 05, 2025
This campaign is to raise awareness about the crucial role helmet usage plays in saving lives
Terray Therapeutics hits milestone in collaboration with Bristol Myers Squibb
By IPP Bureau - December 05, 2025
Terray and BMS aim to accelerate small molecule drug discovery by harnessing EMMI’s integrated experimental and AI capabilities
Excelsior Sciences raises $95 million for drug discovery with AI-ready chemistry
By IPP Bureau - December 05, 2025
Excelsior aims to make reshoring affordable and strategic, shielding nations from geopolitical disruptions
Peapod Bio teams up with Enamine to supercharge drug discovery
By IPP Bureau - December 05, 2025
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
Eurofins launches first GMP PFAS testing solution for medical devices
By IPP Bureau - December 05, 2025
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
Lupin receives FDA’s tentative approval for Siponimod tablets
By IPP Bureau - December 05, 2025
Siponimod Tablets is indicated for the treatment of relapsing forms of multiple sclerosis
Senores Pharmaceuticals receives Philippine FDA approval for 10 products
By IPP Bureau - December 05, 2025
Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region
Industry-academia partnership key to advancing R&D agenda, says Dr. Jitendra Singh
By IPP Bureau - December 05, 2025
Growing patent filings and tier-2 innovators reflect expanding national research base
DBT, BIRAC and CEPI renew cooperation agreement for vaccine development
By IPP Bureau - December 05, 2025
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
Briefs: Sun Pharma and Venus Remedies
By IPP Bureau - December 04, 2025
Sun Pharma to set up Rs. 3,000 crore greenfield formulations facility in MP
Kytopen & TQ Therapeutics forge partnership to advance next-generation cell therapies
By IPP Bureau - December 04, 2025
The partnership aims to combine TQx’s in vivo therapeutic expertise with Kytopen’s continuous flow transfection technology
Wellcome injects £2 million to turbocharge UK regulation of digital mental health tech
By IPP Bureau - December 04, 2025
